Keros Therapeutics Inc. (KROS)
10.79
-1.69 (-13.54%)
At close: Jan 15, 2025, 10:31 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 151.00K | n/a | 20.10M | n/a | 10.00M | 10.00M |
| Cost of Revenue | 815.00K | 1.61M | 898.00K | 605.00K | 17.35M | 10.11M |
| Gross Profit | -664.00K | -1.61M | 19.20M | -605.00K | -7.35M | -111.00K |
| Operating Income | -169.94M | -114.79M | -56.37M | -46.66M | -10.56M | -1.69M |
| Interest Income | n/a | 1K | 4.00K | 6.00K | 8.00K | 6.00K |
| Pretax Income | -152.99M | -104.68M | -56.73M | -45.53M | -12.34M | -1.08M |
| Net Income | -152.99M | -104.68M | -58.74M | -45.36M | -12.34M | -1.33M |
| Selling & General & Admin | 34.83M | 27.52M | 21.33M | 12.80M | 3.18M | 1.58M |
| Research & Development | 135.26M | 87.27M | 55.14M | 33.86M | 17.38M | 10.11M |
| Other Expenses | n/a | -7.08M | -356.00K | -2.46M | -558.00K | 237.00K |
| Operating Expenses | 170.09M | 107.71M | 76.47M | 44.20M | 20.00M | 11.32M |
| Interest Expense | n/a | 1K | 4.00K | 6.00K | 8.00K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 170.09M | 107.71M | 76.47M | 44.20M | 20.00M | 11.32M |
| Income Tax | n/a | 1K | 2.01M | -172.00K | 8.00K | 257.00K |
| Shares Outstanding (Basic) | 29.45M | 25.24M | 23.33M | 15.51M | 8.88M | 8.88M |
| Shares Outstanding (Diluted) | 29.45M | 25.24M | 23.33M | 15.51M | 8.88M | 8.88M |
| EPS (Basic) | -5.2 | -4.15 | -2.52 | -2.93 | -1.39 | -0.15 |
| EPS (Diluted) | -5.2 | -4.15 | -2.52 | -2.93 | -1.39 | -0.15 |
| EBITDA | -152.18M | -103.06M | -56.37M | -44.92M | -11.89M | -774.00K |
| Depreciation & Amortization | 815.00K | 1.61M | 898.00K | 605.00K | 438.00K | 304.00K |